Myeloid leukemia

Results: 723



#Item
91Carcinogenesis / Myeloid leukemia / Drugs / Targeted therapy / Personalized medicine / Imatinib / Cancer / Gastrointestinal stromal tumor / Chronic myelogenous leukemia / Medicine / Oncology / Lymphoma

Tyler Vestal, Columbia University College of Physicians and Surgeons    It took nearly 13 years and cost over $3 billion to sequence the human genome for the first time, a task that  was 

Add to Reading List

Source URL: blog.23andme.com

Language: English - Date: 2014-04-25 14:13:55
92Health / Acute myeloid leukemia / Myelodysplastic syndrome / Leukemia / Eisai / Clinical trial / Medicine / Acute leukemia / Myeloid leukemia

July 20, 2012 DACOGEN(R) Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia DUBLIN, Calif., July 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:

Add to Reading List

Source URL: astx.com

Language: English
93Prognosis / Breast cancer / Evidence-based medicine / Clinical research / Epidemiology / Randomized controlled trial / Acute myeloid leukemia / Medicine / Health / Medical terms

Critical appraisal of Prognostic studies Are the results of the study valid? (Internal Validity) 1.Was the defined representative sample of patients assembled at a common (usually early) point in the course of their dise

Add to Reading List

Source URL: www.cebm.net

Language: English - Date: 2014-06-12 06:43:06
94Biomarker / Medicine / Astex / Acute myeloid leukemia

September 30, 2013 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at the European Cancer Congress DUBLIN, Calif., Sept. 30, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a ph

Add to Reading List

Source URL: astx.com

Language: English
95Leukemia / Epigenetics / Biology / Myelodysplastic syndrome / Syndromes / Acute myeloid leukemia

SuperGen Announces Enrollment of First Patient in First in Human Trial of SGI-110 in MDS and AML Patients DUBLIN, Calif., Jan 05, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG) today announced that it has enrolled th

Add to Reading List

Source URL: astx.com

Language: English
96Alkylating antineoplastic agents / Acute leukemia / Acute myeloid leukemia / Myeloid leukemia / Myelodysplastic syndrome / Carboplatin / Chemistry / Oncology / Medicine

April 10, 2013 Astex Pharmaceuticals Provides SGI-110 Update Oral Presentation at AACR Supports Potential of SGI-110 In The Treatment Of Platinum-Resistant Ovarian Cancer Clinical Update on SGI[removed]Study DUBLIN, Cali

Add to Reading List

Source URL: astx.com

Language: English
97Myelodysplastic syndrome / Syndromes / Acute myeloid leukemia / Eisai / Neutropenia / Decitabine / Anemia / Medicine / Oncology / Health

Eisai Inc. Receives Complete Response Letter from the U.S. Food and Drug Administration for Dacogen® (decitabine) for Injection sNDA in Acute Myeloid Leukemia DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc

Add to Reading List

Source URL: astx.com

Language: English
98Acute leukemia / Acute myeloid leukemia / Myeloid leukemia / Design of experiments / Myelodysplastic syndrome / Clinical trial / Medicine / Health / Clinical research

December 10, 2012 Astex Pharmaceuticals Announces Results From Dose Escalation Part of SGI-110 Phase 1/2 MDS and AML Study in an Oral Presentation at ASH DUBLIN, Calif., Dec. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceu

Add to Reading List

Source URL: astx.com

Language: English
99Acute myeloid leukemia / Myeloid leukemia / Clinical research / Design of experiments / Myelodysplastic syndrome / Astex / Clinical trial / Medicine / Health / Acute leukemia

June 22, 2012 Astex Pharmaceuticals Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients DUBLIN, Calif., June 22, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasd

Add to Reading List

Source URL: astx.com

Language: English
100Syndromes / Acute myeloid leukemia / Leukemia / Neutropenia / Thrombocytopenia / Decitabine / Medicine / Oncology / Myelodysplastic syndrome

Astex Announces FDA ODAC Meeting of sNDA Application for Dacogen in Treatment of Elderly AML DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), today announced the pre-publication notice of the

Add to Reading List

Source URL: astx.com

Language: English
UPDATE